AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 52 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $134,000 | -23.4% | 15,006 | 0.0% | 0.10% | -26.1% |
Q3 2020 | $175,000 | -27.4% | 15,006 | 0.0% | 0.14% | -18.3% |
Q2 2020 | $241,000 | +186.9% | 15,006 | 0.0% | 0.17% | +103.6% |
Q1 2020 | $84,000 | -51.4% | 15,006 | +14.4% | 0.08% | -28.4% |
Q4 2019 | $173,000 | – | 13,113 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,300,000 | $17,160,000 | 2.55% |
Alphabet Inc. | 699,352 | $9,231,000 | 0.56% |
DAFNA Capital Management LLC | 100,000 | $1,320,000 | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 705,356 | $9,311,000 | 0.29% |
Artal Group S.A. | 500,000 | $6,600,000 | 0.26% |
Cormorant Asset Management, LP | 479,988 | $6,336,000 | 0.25% |
MPM BioImpact LLC | 39,740 | $525,000 | 0.19% |
Granahan Investment Management | 305,158 | $4,028,000 | 0.18% |
Burrage Capital Management LLC | 13,113 | $173,000 | 0.12% |
Vident Investment Advisory, LLC | 118,866 | $1,569,000 | 0.10% |